Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bonyf NVXPAR:MLBON 12 Gross Margin % is 8.19% as of Dec. 2024, which is 3% below its 10-year median of 8.41. GuruFocus rates XPAR:MLBON with a GF Score™ of 12/100 and a GF Value™ of €8.61 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Bonyf NV ranks worse than 95.29% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Bonyf NV's Gross Profit for the
six
months ended in Dec. 2024 was €0.02 Mil. Bonyf NV's Revenue for the
six
months ended in Dec. 2024 was €0.28 Mil. Therefore, Bonyf NV's Gross Margin % for the quarter that ended in Dec. 2024 was 8.19%.
The historical rank and industry rank for Bonyf NV's Gross Margin % or its related term are showing as below:
XPAR:MLBON'
s Gross Margin % Range Over the Past 10 Years
Min: 3.61 Med: 8.41 Max: 69.86
Current: 8.19
During the past 5 years, the highestGross Margin % of Bonyf NV was 69.86%. The lowest was 3.61%. And the median was 8.41%.
XPAR:MLBON's Gross Margin % is ranked worse than 95.29% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 52.115
vs XPAR:MLBON: 8.19
Bonyf NV had a gross margin of 8.19% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Bonyf NV was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Bonyf NV had a gross margin of 8.19% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Bonyf NV Gross Margin % Related Terms
Bonyf NV Gross Margin % Historical Data
* Premium members only.
The historical data trend for Bonyf NV's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bonyf NV Gross Margin % Chart
Bonyf NV Annual Data
Trend
Dec19
Dec20
Dec22
Dec23
Dec24
Gross Margin %
67.43
69.86
3.61
8.41
8.19
Bonyf NV Semi-Annual Data
Dec19
Dec20
Dec22
Dec23
Dec24
Gross Margin %
67.43
69.86
3.61
8.41
8.19
XPAR:MLBON vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Bonyf NV's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bonyf NV Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bonyf NV's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Bonyf NV's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Bonyf NV (XPAR:MLBON) has a Gross Margin % of 8.19% as of Dec. 2024. Gross margin is the ratio of total gross profit to net sales. View historical data on Bonyf NV and its competitors. This is near median its historical median of 8.41. Over the past decade, Bonyf NV's Gross Margin % has ranged from 3.61 to 69.86. According to the industry distribution chart, Bonyf NV ranks #768 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 95.3%.
Is Bonyf NV's Gross Margin % too high?
Bonyf NV's current Gross Margin % of 8.19% is near median its 10-year median of 8.41. Over the past 10 years, this metric has ranged from a low of 3.61 to a high of 69.86. The Medical Devices & Instruments industry median Gross Margin % is 52.12. Bonyf NV's value of 8.19% is 84.3% below this industry median. Based on the distribution chart, Bonyf NV ranks #768 out of 806 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bonyf NV has a GF Score™ of 12/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bonyf NV's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bonyf NV ranks #768 out of 806 companies for Gross Margin %. This places Bonyf NV in the lower half of its industry. The industry median Gross Margin % is 52.12. Bonyf NV's value of 8.19% is 84.3% below this benchmark. Historically, Bonyf NV's own Gross Margin % has ranged from 3.61 to 69.86 over the past decade. While the company's 10-year median is 8.41 vs. the industry median of 52.12, Bonyf NV has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.12, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bonyf NV's current Gross Margin % of 8.19% is 84.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Bonyf NV and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bonyf NV's current Gross Margin % is 8.19%, which is near median its own 10-year median of 8.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonyf NV stock overvalued right now?
Based on GuruFocus' analysis, Bonyf NV (XPAR:MLBON) is currently considered Possible Value Trap. The stock's GF Value™ is €8.61, compared to a current price of €2.48 — trading 71.2% below its estimated fair value. The current Gross Margin % is 8.19%, which is near median its 10-year median of 8.41 and 84.3% below the Medical Devices & Instruments industry median of 52.12. Bonyf NV's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Bonyf NV (XPAR:MLBON), the current Gross Margin % is 8.19% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bonyf NV (XPAR:MLBON) Overvalued in 2026?
Based on GuruFocus' analysis, Bonyf NV stock appears to be undervalued.
The current stock price of €2.48 is trading 71.2% below its estimated GF Value™ of €8.61.
GuruFocus considers Bonyf NV to be Possible Value Trap.
Key valuation signals for XPAR:MLBON:
Gross Margin %: 8.19% (near median its 10-year median of 8.41)
GF Value™: €8.61 vs. price of €2.48 (71.2% below fair value)
Industry Position: 84.3% below the Medical Devices & Instruments median (#768 of 806)
No single metric tells the full story. See the XPAR:MLBON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bonyf NV specializes in developing, producing and selling cutting-edge oral & dental care products. It is a forward-thinking company committed to revolutionizing oral care through innovation and research.
12GF Score
Get the complete analysis for XPAR:MLBON
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLBON has been successfully added to your 
